Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial

Rodriguez, G. D., Warren, N., Yashayev, R., Chitra, S., Amodio-Groton, M., & Wright, K. (2023). Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1225710
Authors:
George D Rodriguez
Nathan Warren
Roman Yashayev
Surya Chitra
Maria Amodio-Groton
Kelly Wright
Affiliated Authors:
George D Rodriguez
Nathan Warren
Roman Yashayev
Columbia Affiliation:
Author Keywords:
antibiotic resistance
community-acquired bacterial pneumonia
fluoroquinolones
omadacycline
oral antibiotics
elink
Publication Type:
Article
Unique ID:
10.3389/fmed.2023.1225710
PMID:
37575994
DOI:
10.3389/fmed.2023.1225710
Journal:
Frontiers in Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: